See more : Grupo Ezentis, S.A. (EZE.MC) Income Statement Analysis – Financial Results
Complete financial analysis of Perimeter Solutions, SA (PRM) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Perimeter Solutions, SA, a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- Grupo Security S.A. (SECURITY.SN) Income Statement Analysis – Financial Results
- Greenpanel Industries Limited (GREENPANEL.BO) Income Statement Analysis – Financial Results
- Tunghsu Azure Renewable Energy Co.,Ltd. (000040.SZ) Income Statement Analysis – Financial Results
- Fujitsu Limited (6702.T) Income Statement Analysis – Financial Results
- LS Invest AG (IFA.DE) Income Statement Analysis – Financial Results
Perimeter Solutions, SA (PRM)
About Perimeter Solutions, SA
Perimeter Solutions, SA manufactures and supplies firefighting products and lubricant additives in the United States, Germany, and internationally. It operates in two segments, Fire Safety and Oil Additives. The Fire Safety segment provides fire retardants and firefighting foams, as well as specialized equipment and services for federal, state, provincial, local/municipal, and commercial customers. The Oil Additives segment produces Phosphorus Pentasulfide which is primarily used in the preparation of lubricant additives, including a family of compounds called Zinc Dialkyldithiophosphates. The company offers its products under the brands PHOS-CHEK, FIRE-TROL, AUXQUIMIA, SOLBERG. and BIOGEMA. Perimeter Solutions, SA was founded in 1963 and is headquartered in Clayton, Missouri.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 322.11M | 360.51M | 362.34M | 339.58M | 239.31M |
Cost of Revenue | 183.25M | 217.85M | 249.27M | 177.53M | 155.43M |
Gross Profit | 138.86M | 142.65M | 113.06M | 162.05M | 83.88M |
Gross Profit Ratio | 43.11% | 39.57% | 31.20% | 47.72% | 35.05% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 108.48M | 117.30M | 652.99M | 37.75M | 36.20M |
Selling & Marketing | -51.41M | -42.98M | -597.03M | 0.00 | 0.00 |
SG&A | 57.07M | 74.32M | 55.96M | 37.75M | 36.20M |
Other Expenses | -12.67M | -61.73M | -657.24M | 52.82M | 53.46M |
Operating Expenses | 44.41M | 12.59M | 713.20M | 90.57M | 89.66M |
Cost & Expenses | 227.66M | 230.44M | 962.47M | 268.10M | 245.09M |
Interest Income | 0.00 | 42.59M | 45.44M | 42.02M | 51.66M |
Interest Expense | 41.38M | 42.59M | 45.44M | 42.02M | 51.66M |
Depreciation & Amortization | 64.86M | 71.20M | 61.43M | 58.12M | 58.03M |
EBITDA | 173.07M | 211.01M | -546.68M | 134.87M | 49.97M |
EBITDA Ratio | 53.73% | 54.47% | -148.67% | 38.05% | 22.00% |
Operating Income | 94.45M | 130.07M | -600.13M | 71.48M | -5.37M |
Operating Income Ratio | 29.32% | 36.08% | -165.63% | 21.05% | -2.24% |
Total Other Income/Expenses | -32.87M | -32.84M | -53.41M | -36.74M | -53.93M |
Income Before Tax | 61.58M | 97.23M | -653.54M | 34.73M | -59.71M |
Income Before Tax Ratio | 19.12% | 26.97% | -180.37% | 10.23% | -24.95% |
Income Tax Expense | -5.90M | 5.47M | 7.98M | 10.48M | -17.67M |
Net Income | 67.49M | 91.76M | -661.52M | 24.25M | -42.04M |
Net Income Ratio | 20.95% | 25.45% | -182.57% | 7.14% | -17.57% |
EPS | 0.44 | 0.57 | -4.21 | 0.46 | -0.79 |
EPS Diluted | 0.41 | 0.52 | -4.21 | 0.46 | -0.79 |
Weighted Avg Shares Out | 154.67M | 160.94M | 157.24M | 53.05M | 53.05M |
Weighted Avg Shares Out (Dil) | 166.45M | 175.08M | 157.24M | 53.05M | 53.05M |
Uk: The process of bringing back the human remains of the Naga community from the British Museum continues.
Muck Rack’s Global Media Monitoring Now Covers Over 600,000 Outlets
Harvest Declares Big Pharma Split Corp. March 2023 Distributions
Harvest déclare les distributions de mars 2023 de Société à capital scindé Grandes pharmaceutiques
Harvest Declares Big Pharma Split Corp. February 2023 Distribution
Harvest déclare la distribution de février 2023 de Société à capital scindé Grandes pharmaceutiques
Harvest Declares Big Pharma Split Corp. January 2023 Distribution
Harvest déclare la distribution de janvier 2023 de Société à capital scindé Grandes pharmaceutiques
Harvest Declares Big Pharma Split Corp. December 2022 Distributions
Harvest déclare les distributions de décembre 2022 de Société à capital scindé Grandes pharmaceutiques
Source: https://incomestatements.info
Category: Stock Reports